TARATOR LIMITED
Company number 15221511 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
TARATOR LIMITED - Analysis Report
Company Number: 15221511
Analysis Date: 2025-07-29 16:55 UTC
Financial Health Assessment for TARATOR LIMITED
1. Financial Health Score: D
Explanation:
TARATOR LIMITED shows early-stage financial challenges typical of a newly incorporated company. Despite having cash on hand, the company has a slight net liability position and negative shareholders' funds. This indicates initial financial distress "symptoms," though the scale is small and potentially manageable with proper financial controls. The company is not yet profitable, reflecting normal start-up dynamics, but it must monitor liquidity carefully to avoid worsening health.
2. Key Vital Signs
| Metric | Value (£) | Interpretation |
|---|---|---|
| Current Assets | 73,316 | Healthy cash reserves for a start-up, mostly cash (£73,315). |
| Current Liabilities | 73,579 | Slightly exceeds current assets, indicating a working capital deficit. |
| Net Current Assets | -263 | Negative working capital ("cash flow stress") but minimal. |
| Net Assets (Total Equity) | -263 | Company is technically "insolvent" on balance sheet, but only marginally. |
| Shareholders' Funds | -264 | Reflects accumulated losses or initial expenses exceeding capital. |
| Debtors | 1 | Minimal trade receivables, typical for a start-up. |
| Loans from Directors | 30,850 | Director loan is a vital liquidity support ("lifeline"). |
Additional Context:
- The company was incorporated in October 2023 and has operated for just over one year.
- The director is also the sole shareholder and has provided personal loans to the company, demonstrating personal financial backing.
- No audit was required due to small company status; accounts comply with FRS 102 Small Entities standard.
3. Diagnosis
TARATOR LIMITED is in the early incubation phase of its business lifecycle, exhibiting typical "start-up symptoms" such as initial losses and negative equity. The company's cash balance is strong relative to its size, but current liabilities slightly exceed current assets, showing a mild liquidity strain. The presence of director loans indicates reliance on internal financing rather than external credit or operational cash flow.
The negative shareholders' funds and net liabilities indicate that the company has invested in establishing operations but has not yet generated profits or retained earnings. The business operates in software development, which may require further investment in technology and talent before reaching stable revenue generation.
Overall, the financial "vitals" suggest the company is alive but fragile. Without effective cash flow management and eventual revenue growth, the risk of deeper financial distress could increase.
4. Recommendations
Strengthen Cash Flow Management:
- Monitor cash burn rate carefully to avoid running out of liquidity.
- Explore accelerating customer invoicing and collections to improve operational cash flow.
Leverage Director Support Prudently:
- Continue utilizing director loans as a "financial life support" but plan for eventual repayment or conversion to equity to strengthen balance sheet.
Focus on Revenue Generation:
- Prioritize securing contracts or sales to convert technical development into cash inflows.
- Consider staged business milestones aligned with cash flow targets.
Cost Control:
- Maintain tight control on expenses, especially discretionary spending, to preserve cash reserves.
Prepare for Growth Capital:
- If expansion is planned, explore external funding options (e.g., bank loans, angel investors) before liquidity pressures intensify.
Regular Financial Reviews:
- Implement monthly financial reporting to identify emerging issues early and adjust operations proactively.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.